1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
173.56%
Revenue growth above 1.5x 6203.T's 5.98%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
81.63%
Gross profit growth above 1.5x 6203.T's 16.80%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
253.58%
EBIT growth above 1.5x 6203.T's 100.66%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
299.78%
Operating income growth above 1.5x 6203.T's 75.38%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
419.93%
Net income growth above 1.5x 6203.T's 9.20%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
419.48%
EPS growth above 1.5x 6203.T's 9.22%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
419.48%
Diluted EPS growth above 1.5x 6203.T's 9.22%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-84.40%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
14.43%
Positive 5Y CAGR while 6203.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
67.84%
Positive 3Y CAGR while 6203.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
105.75%
Net income/share CAGR above 1.5x 6203.T's 9.62% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-28.00%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
253.81%
Positive short-term CAGR while 6203.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
-64.77%
Negative equity/share CAGR over 10 years while 6203.T stands at 17.75%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
138.62%
5Y equity/share CAGR above 1.5x 6203.T's 21.61%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
24.93%
Positive short-term equity growth while 6203.T is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
128.89%
Our AR growth while 6203.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-58.42%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.52%
Positive asset growth while 6203.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
8.07%
Positive BV/share change while 6203.T is negative. John Neff sees a clear edge over a competitor losing equity.
-4.53%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-18.56%
Our R&D shrinks while 6203.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
142.69%
We expand SG&A while 6203.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.